PERSPECTA

News from every angle

Back to headlines

AstraZeneca Reports Positive Interim Results from I CAN Phase III Trial

AstraZeneca PLC announced positive findings from a prespecified interim analysis of its I CAN Phase III clinical trial, indicating promising results for the studied treatment.

27 Apr, 06:05 — 27 Apr, 06:05
PostShare

Sources

Showing 1 of 1 sources